Skip to main content
SBER21/AER21 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Pre-Reg Required
Pre-Reg Required
New for 2020
New for 2020
CSP Icon
CSP Icon
Livestreaming Session Icon
Livestreaming Session Icon
On-Demand Session
On-Demand Session
CIP Accredited
CIP Accredited
Additional Fee
Additional Fee
Poster Icons
Record Session Icon
Record Session Icon
Pre-Reg Required
Pre-Reg Required
New for 2020
New for 2020
Part I/II
Part I/II
CSP Icon
CSP Icon
Livestreaming Session Icon
Livestreaming Session Icon
Prerecorded Session Icon
Prerecorded Session Icon
CIP Accredited
CIP Accredited
Pillars Icon
Pillars Icon
Back

David Fajgenbaum, MD, MBA, MSc

University of Pennsylvania

David Fajgenbaum, MD, MBA, MSc, is a groundbreaking physician-scientist, disease hunter, speaker, and national bestselling author of Chasing My Cure: A Doctor's Race to Turn Hope Into Action. He went from being a beast-like college quarterback to receiving his last rites while in medical school and nearly dying four more times battling Castleman disease. To try to save his own life, Dr. Faigenbaum spearheaded an innovative approach to research through the Castleman Disease Collaborative Network (CDCN) and discovered a treatment that is saving his life and others. Given the similarities between COVID-19 and Castleman disease, Dr. Fajgenbaum launched the CORONA project in March 2020 to identify and track treatments for COVID-19. CORONA is the world’s largest database of COVID-19 treatments, including 400+ medications that have been administered to 280,000+. Now, he is leading the effort to find treatments for Castleman disease, COVID-19, and other diseases as co-Founder & President of the CDCN, Director of the Center for Cytokine Storm Treatment & Laboratory (CSTL) at the University of Pennsylvania, and a co-director of an FDA/NIH/C-Path public-private partnership called the CURE Drug Repurposing Collaboratory.

One of the youngest individuals ever appointed to the faculty at Penn Medicine and the top one percent youngest grant awardees of a leading NIH grant (R01), Dr. Fajgenbaum has been profiled in a cover story by The New York Times, recognized on the Forbes 30 Under 30 list, as a top healthcare leader by Becker's Hospital Review, the Global Genes RARE Champion of Hope: Science awardee, and one of three recipients of a 2016 Atlas Award from the World Affairs Council of Philadelphia. He has published scientific papers in high-impact journals such as the New England Journal of Medicine, The Lancet, and the Journal of Clinical Investigation, including a paper selected as one of the top innovations in science and medicine by STAT News in 2020. Before co-founding the CDCN, Dr. Faigenbaum co-founded and led the Actively Moving Forward Support Network, a non-profit organization dedicated to supporting grieving college students.

Dr. Faigenbaum earned a BS from Georgetown University magna cum laude with honors and distinction, MSc from the University of Oxford, MD from the University of Pennsylvania, and MBA from The Wharton School.

Disclosure information not submitted.

Presentation(s):